Shares of Extendicare Inc. (TSE:EXE – Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as C$10.60 and last traded at C$10.60, with a volume of 15813 shares trading hands. The stock had previously closed at C$10.38.
Wall Street Analysts Forecast Growth
EXE has been the subject of several recent analyst reports. Royal Bank of Canada upped their target price on shares of Extendicare from C$8.50 to C$9.50 in a report on Monday, August 19th. TD Securities upped their price objective on Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a research note on Thursday, November 14th.
Extendicare Stock Performance
Extendicare Dividend Announcement
The business also recently declared a monthly dividend, which was paid on Friday, November 15th. Shareholders of record on Thursday, October 31st were issued a $0.04 dividend. The ex-dividend date of this dividend was Thursday, October 31st. This represents a $0.48 dividend on an annualized basis and a yield of 4.55%. Extendicare’s dividend payout ratio is currently 70.59%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Recommended Stories
- Five stocks we like better than Extendicare
- Do ETFs Pay Dividends? What You Need to Know
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.